Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20,336 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers.
Westerhout CM, Fu Y, Lauer MS, James S, Armstrong PW, Al-Hattab E, Califf RM, Simoons ML, Wallentin L, Boersma E; GUSTO-IV ACS Trial Investigators. Westerhout CM, et al. Among authors: fu y. J Am Coll Cardiol. 2006 Sep 5;48(5):939-47. doi: 10.1016/j.jacc.2006.04.085. J Am Coll Cardiol. 2006. PMID: 16949483 Free article.
Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy.
Taher T, Fu Y, Wagner GS, Goodman SG, Fresco C, Granger CB, Wallentin L, van de Werf F, Verheugt F, Armstrong PW. Taher T, et al. Among authors: fu y. J Am Coll Cardiol. 2004 Jul 7;44(1):38-43. doi: 10.1016/j.jacc.2004.03.041. J Am Coll Cardiol. 2004. PMID: 15234403 Free article. Clinical Trial.
Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
Armstrong PW, Fu Y, Westerhout CM, Hudson MP, Mahaffey KW, White HD, Todaro TG, Adams PX, Aylward PE, Granger CB. Armstrong PW, et al. Among authors: fu y. J Am Coll Cardiol. 2009 Apr 28;53(17):1503-9. doi: 10.1016/j.jacc.2009.01.046. J Am Coll Cardiol. 2009. PMID: 19389560 Free article. Clinical Trial.
Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Tjandrawidjaja MC, Fu Y, Westerhout CM, Wagner GS, Granger CB, Armstrong PW; APEX-AMI Investigators. Tjandrawidjaja MC, et al. Among authors: fu y. Am J Cardiol. 2010 Sep 1;106(5):630-4. doi: 10.1016/j.amjcard.2010.04.013. Am J Cardiol. 2010. PMID: 20723636 Clinical Trial.
Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial.
Toma M, Fu Y, Ezekowitz JA, McAlister FA, Westerhout CM, Granger CB, Armstrong PW. Toma M, et al. Among authors: fu y. Am Heart J. 2010 Oct;160(4):671-7. doi: 10.1016/j.ahj.2010.06.054. Am Heart J. 2010. PMID: 20934561 Clinical Trial.
20,336 results
You have reached the last available page of results. Please see the User Guide for more information.